SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-18-007117
Filing Date
2018-06-28
Accepted
2018-06-28 17:00:26
Documents
1
Period of Report
2018-06-26

Document Format Files

Seq Description Document Type Size
1 FORM4 section16.html 4  
1 FORM4 section16.xml 4 3154
  Complete submission text file 0001654954-18-007117.txt   4813
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address
SCHOENEBAUM MARK (Reporting) CIK: 0001548537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 18926102